{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:42:39Z","timestamp":1787244159221,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ijom.2017.04.020","type":"journal-article","created":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T19:00:32Z","timestamp":1494874832000},"page":"1417-1423","source":"Crossref","is-referenced-by-count":19,"title":["Localized myofascial pain responds better than referring myofascial pain to botulinum toxin injections"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3190-8834","authenticated-orcid":false,"given":"W.A.","family":"Abboud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hassin-Baer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Joachim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Givol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Yahalom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijom.2017.04.020_bib0005","series-title":"Temporomandibular disorders: an evidence-based approach to diagnosis and treatment","first-page":"255","article-title":"Masticatory Muscle Pain and Dysfunction","author":"Gonzalez","year":"2006"},{"key":"10.1016\/j.ijom.2017.04.020_bib0010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.11607\/jop.1151","article-title":"iagnostic Criteria for Temporomandibular Disorders (DC\/TMD) for Clinical and Research Applications: Recommendations of the International RDC\/TMD Consortium Network and Orofacial Pain Special Interest Group","volume":"28","author":"Schiffman","year":"2014","journal-title":"J Oral Facial Pain Headache"},{"key":"10.1016\/j.ijom.2017.04.020_bib0015","first-page":"39","article-title":"Type A botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity","volume":"101","author":"von Lindern","year":"2001","journal-title":"JOMS"},{"key":"10.1016\/j.ijom.2017.04.020_bib0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijom.2009.10.022","article-title":"Clinical use of botulinum toxins in oral and maxillofacial surgery","volume":"39","author":"Majid","year":"2010","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2017.04.020_bib0025","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bjoms.2012.07.002","article-title":"Botulinum injection for the management of myofascial pain in the masticatory muscles. A prospective outcome study","volume":"51","author":"Sidebottom","year":"2013","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2017.04.020_bib0030","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0278-2391(99)90007-1","article-title":"The use of botulinum toxin for the treatment of temporomandibular disorders: preliminary findings","volume":"57","author":"Freund","year":"1999","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2017.04.020_bib0035","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.joms.2010.05.042","article-title":"Intramuscular injection of botulinum toxin as an adjunct to arthrocentesis: preliminary reports","volume":"69","author":"Freund","year":"2011","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2017.04.020_bib0040","article-title":"Botulinum toxin for myofascial pain syndromes in adults","volume":"7","author":"Soares","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijom.2017.04.020_bib0045","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1213\/ANE.0000000000000192","article-title":"Botulinum toxin type a injections for cervical and shoulder girdle myofascial pain using an enriched protocol design","volume":"118","author":"Nicol","year":"2014","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ijom.2017.04.020_bib0050","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/j.1526-4637.2011.01163.x","article-title":"Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections","volume":"12","author":"Benecke","year":"2011","journal-title":"Pain Med"},{"key":"10.1016\/j.ijom.2017.04.020_bib0055","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0304-3959(94)90048-5","article-title":"Botulinum toxin in the treatment of myofascial pain syndrome","volume":"59","author":"Cheshire","year":"1994","journal-title":"Pain"},{"key":"10.1016\/j.ijom.2017.04.020_bib0060","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s00296-004-0485-6","article-title":"Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome","volume":"25","author":"Kamanli","year":"2005","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.ijom.2017.04.020_bib0065","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0304-3959(99)00264-X","article-title":"A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm","volume":"85","author":"Porta","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.ijom.2017.04.020_bib0070","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.joms.2011.05.030","article-title":"Botulinum toxin A in the treatment of myofascial pain and dysfunction: The case against its use","volume":"70","author":"Laskin","year":"2012","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2017.04.020_bib0075","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.joms.2008.03.008","article-title":"Effect of Botulinum toxin-A in myofascial pain patients with or without functional disc displacement","volume":"66","author":"Kurtoglu","year":"2008","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2017.04.020_bib0080","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0304-3959(01)00358-X","article-title":"Botulinum toxin A for the treatment of chronic neck pain","volume":"94","author":"Wheeler","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.ijom.2017.04.020_bib0085","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1097\/00007632-199808010-00009","article-title":"A randomized, double blind, prospecive pilot study of BTX injection for refractory, unilateral, cervicothoracic, paraspinal MPS","volume":"23","author":"Wheeler","year":"1998","journal-title":"Spine (Phila PA)"},{"key":"10.1016\/j.ijom.2017.04.020_bib0090","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.pain.2011.03.036","article-title":"Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: a randomized, controlled, double-blind multicenter study","volume":"152","author":"Ernberg","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.ijom.2017.04.020_bib0095","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.pain.2005.08.012","article-title":"Botulinum toxin A versus bupivacaine trigger point injections for the treatment of myofascial pain syndrome: a randomised double blind crossover study","volume":"118","author":"Graboski","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.ijom.2017.04.020_bib0100","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0304-3959(02)00240-3","article-title":"Randomized controlled trial of botulinum toxin A for chronic myogenous orofacial pain","volume":"99","author":"Nixdorf","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.ijom.2017.04.020_bib0105","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1212\/01.wnl.0000224731.06168.df","article-title":"A double-blind, controlled study of botulinum toxin A in chronic myofascial pain","volume":"67","author":"Qerama","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.ijom.2017.04.020_bib0110","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/01.ajp.0000151871.51406.c3","article-title":"The effect of small doses of botulinum toxin a on neck-shoulder myofascial pain syndrome: a double-blind, randomized, and controlled crossover trial","volume":"22","author":"Ojala","year":"2006","journal-title":"Clin J Pain"},{"key":"10.1016\/j.ijom.2017.04.020_bib0115","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11916-013-0386-z","article-title":"An update on botulinum toxin a injections of trigger points for myofascial pain","volume":"18","author":"Zhou","year":"2014","journal-title":"Curr Pain Headache Rep"},{"issue":"Suppl. 1","key":"10.1016\/j.ijom.2017.04.020_bib0120","doi-asserted-by":"crossref","first-page":"I\/36","DOI":"10.1007\/s00415-004-1109-5","article-title":"Pongratz, Consensus statement: Botulinum toxin in myofacial pain Myofascial","volume":"251","author":"Reilich","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.ijom.2017.04.020_bib0125","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cden.2006.10.002","article-title":"Myogenous temporomandibular disorders: diagnostic and management considerations","volume":"51","author":"Fricton","year":"2007","journal-title":"Dent Clin North Am"},{"key":"10.1016\/j.ijom.2017.04.020_bib0130","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.coms.2007.12.003","article-title":"Classification, causation and treatment of masticatory myogenous pain and dysfunction","volume":"20","author":"Clark","year":"2008","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"10.1016\/j.ijom.2017.04.020_bib0135","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.coms.2007.12.005","article-title":"Pharmacologic management of temporomandibular disorders","volume":"20","author":"Hersh","year":"2008","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"10.1016\/j.ijom.2017.04.020_bib0140","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0889-8537(03)00082-8","article-title":"Botulinum toxin therapy in pain management","volume":"21","author":"Raj","year":"2003","journal-title":"Anesth Clin North Am"},{"key":"10.1016\/j.ijom.2017.04.020_bib0145","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00002508-200307000-00011","article-title":"Use of botulinum toxin in the treatment of chronic myofascial pain","volume":"19","author":"De Andr\u00e9s","year":"2003","journal-title":"Clin J Pain"},{"key":"10.1016\/j.ijom.2017.04.020_bib0150","series-title":"Temporomandibular disorders: an evidence-based approach to diagnosis and treatment","first-page":"99","article-title":"Muscular Pain and Dysfunction","author":"Lund","year":"2006"},{"key":"10.1016\/j.ijom.2017.04.020_bib0155","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0003-9993(98)90371-9","article-title":"Pathophysiologic and electrophysiologic mechanisms of myofascial trigger points","volume":"79","author":"Hong","year":"1998","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.ijom.2017.04.020_bib0160","series-title":"Myofascial pain and dysfunction: the trigger point manual","year":"1999"},{"key":"10.1016\/j.ijom.2017.04.020_bib0165","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/08869634.2001.11746165","article-title":"Electromyographic evidence of reduced muscle activity when ULF-TENS is applied to the Vth and VIIth cranial nerves","volume":"19","author":"Kamyszek","year":"2001","journal-title":"Cranio"},{"key":"10.1016\/j.ijom.2017.04.020_bib0170","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/01.PHM.0000143399.34798.A7","article-title":"Effect of increased sympathetic activity on electrical activity from myofascial painful areas","volume":"83","author":"Chung","year":"2004","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.ijom.2017.04.020_bib0175","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.ijom.2015.04.003","article-title":"Botulinum toxin therapy for temporomandibular joint disorders: a systematic review of randomized controlled trials","volume":"44","author":"Chen","year":"2015","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2017.04.020_bib0180","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1139\/y91-102","article-title":"The pain adaptation model: a discussion of the relationship between chronic musculoskeletal pain and motor activity","volume":"69","author":"Lund","year":"1991","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.ijom.2017.04.020_bib0185","first-page":"126","article-title":"Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study","volume":"26","author":"Guarda-Nardini","year":"2008","journal-title":"Cranio J Craniomandib Pract"},{"key":"10.1016\/j.ijom.2017.04.020_bib0190","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/jan.12875","article-title":"How to ask about patient satisfaction? The visual analogue scale is less vulnerable to confounding factors and ceiling effect than a symmetric Likert scale","volume":"72","author":"Voutilainen","year":"2016","journal-title":"J Adv Nurs"},{"key":"10.1016\/j.ijom.2017.04.020_bib0195","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/j.pain.2011.06.003","article-title":"Clinically important difference thresholds of the visual analog scale: a conceptual model for identifying meaningful intraindividual changes for pain intensity","volume":"152","author":"Emshoff","year":"2011","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.ijom.2017.04.020_bib0200","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2340\/00015555-2584","article-title":"Assessing acute itch intensity: general labelled magnitude scale is more reliable than classic visual analogue scale","volume":"97","author":"Jones","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ijom.2017.04.020_bib0205","series-title":"Temporomandibular disorders: an evidence-based approach to diagnosis and treatment","first-page":"89","article-title":"Persistent Orofacial Pain","author":"Ronald","year":"2006"}],"container-title":["International Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S090150271731442X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S090150271731442X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T22:32:08Z","timestamp":1554330728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S090150271731442X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S090150271731442X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijom.2017.04.020","relation":{},"ISSN":["0901-5027"],"issn-type":[{"value":"0901-5027","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}